Back to Search
Start Over
SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer
- Source :
- Breast Cancer: Targets and Therapy, Vol Volume 9, Pp 383-392 (2017)
- Publication Year :
- 2017
- Publisher :
- Dove Medical Press, 2017.
-
Abstract
- Rebecca Johnson,1 Nirupama Sabnis,2 Xiangle Sun,1 Ruhani Ahluwalia,3 Andras G Lacko2,4 1Institute of Molecular Medicine, 2Institute for Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center, 3Harmony School of Innovation, 4Department of Pediatrics, University of North Texas Health Science Center, Fort Worth, TX, USA Abstract: Patients with triple-negative breast cancer (TNBC) have a considerably less favorable prognosis than those with hormone-positive breast cancers. TNBC patients do not respond to current endocrine treatment and have a 5-year survival prognosis of
Details
- Language :
- English
- ISSN :
- 11791314
- Volume :
- ume 9
- Database :
- Directory of Open Access Journals
- Journal :
- Breast Cancer: Targets and Therapy
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f7262946c78546ec9f27e10edded8f4c
- Document Type :
- article